Iowa Department of Public Health will review current substance use disorder rates in Iowa and surveillance to eliminate HIV and HCV throughout the state. The Clinician Consultation Network of University of California San Francisco will review resources available for providers treating hepatitis and co-occurring substance use orders, such as the Warm Line for consultation of cases.
NNCC reviewed how enhanced screening and behavioral health integration improved patient outcomes for hepatitis and opioid use disorder for high risk populations in Philadelphia, PA Boston Health Care for the Homeless discussed the integration of infectious disease and substance use disorder treatment for people experiencing homelessness and in shelters.
A discussion with representatives from the HUD Office of Lead Hazard Control and Healthy Homes during National Lead Poisoning Prevention Week where we learn about best practices for keeping families safe from lead.
NASTAD discusses the current landscape of opioid and infectious disease and resources available for health settings to improve screening, testing, and treatment options for patients.
This webinar provides a national perspective of how the hepatitis C virus (HCV) and opioid use disorder epidemics are connected and what health centers can do to address them. We heard from Lauren Canary from the CDC about expansion of medication-assisted treatment (MAT) and what resources are available to providers.
